ELAB - Wutah pendapatan taun lumaku elevaiskincare.com

Tandha merek elevaiskincare.com (ELAB)

Explosive retail interest and B2B partner loyalty are driving a positive trend for Elevai Labs Inc. (ELAB). The year-over-year dynamics of core revenue over a rolling 12-month period illustrate the current market status, where the value 0.00 captures this metric. Growth is fueled by aesthetic medicine biotechnologies in US laboratories, while strong pricing power in the premium segment guarantees demand for unique regenerative serums.

ELAB (Elevai Labs) riwayat Wutah dodolan YoY (TTM) saka 23.11.2025 nganti 18.11.2026

Elevai Labs - rincian analitis lan metrik utama (ELAB)

- rega saham lan target rega konsensus:
Analisis kabeh metrik perusahaan:Elevai Skincare (ELAB)
Produk mawa merek elevaiskincare.com

This indicator calculates the percentage change in revenue over the last 12 months relative to the same period last year, allowing the investor to assess business scaling dynamics while adjusting for seasonality. For Elevai Labs Inc. (ELAB), the current sales growth rate over the trailing 12-month period year-over-year reflects the effectiveness of the expansion of exosome-based cosmetics within the professional dermatology and aesthetic medicine clinic segments.